IFNG and hepatocellular carcinoma: In vivo studies further confirmed that DMC treatment regulated the gastrointestinal microbiota-AMPK-mTOR axis, increasing the expression of IFN-γ in NK and T cells while inhibiting PD-1 expression, ultimately leading to suppressed HCC growth [49].